Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

100
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
100
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

125
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
125
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

473
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
473
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

103
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
103

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving mortality trends in hypertension-associated ischemic heart disease among U.S. adults over two decades: a CDC wonder analysis (2000-2023).

Journal of human hypertension·2026
Same author

Entomopathogenic fungi: Natural biocontrol of insects, challenges under climate change, advancements and future prospects in Modern Agriculture.

Acta tropica·2025
Same author

Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis.

JAMA ophthalmology·2025
Same author

Advancing Metaverse-Based Healthcare With Multimodal Neuroimaging Fusion via Multi-Task Adversarial Variational Autoencoder for Brain Age Estimation.

IEEE journal of biomedical and health informatics·2025
Same author

Discourse on measurement.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Reply: "Integrity" Assessment Following Rhegmatogenous Retinal Detachment Repair.

Ophthalmic surgery, lasers & imaging retina·2025
Same journal

Retraction: The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia.

Cureus·2026
Same journal

Patient-Reported Understanding of Emergency Department Discharge Instructions, Satisfaction, and Acceptability of a Future Telemedicine-Based Call-Back Program: Phase 1 Observational Pilot Study at a Tertiary Hospital in Dubai, United Arab Emirates.

Cureus·2026
Same journal

Correction: Methylprednisolone-Induced Delayed and Sustained Bradycardia in Multisystem Inflammatory Syndrome in Children.

Cureus·2026
Same journal

Rapid Interval Development of a Left Hepatic Artery Pseudoaneurysm During Acute Interstitial Edematous Pancreatitis.

Cureus·2026
Same journal

Recurrent Acute Pancreatitis Secondary to Untreated Hyperparathyroidism: A Case Report and Literature Review.

Cureus·2026
Same journal

A Prospective Case-Control Study of Helicobacter pylori and Systemic Inflammation in Colorectal Cancer Pathogenesis.

Cureus·2026
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K

Statins and Abnormal Liver Function Tests: Is There a Correlation?

Jibran Ashraf1, M Ali Khan2, Syed Minhaj3

  • 1Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Cureus
|October 5, 2020
PubMed
Summary
This summary is machine-generated.

Statins, commonly used for heart conditions, can cause minor, dose-dependent liver function test elevations over time. These changes are generally insignificant and should not prevent doctors from prescribing or continuing statin therapy.

Keywords:
correlationlftliver function testsstatin

Related Experiment Videos

Last Updated: Dec 6, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K

Area of Science:

  • Cardiology
  • Hepatology
  • Pharmacology

Background:

  • Statins (HMG-CoA reductase inhibitors) are widely prescribed for cardiac patients.
  • Drug-induced liver injury (DILI) from statins can be asymptomatic, necessitating regular liver function tests (LFTs).
  • Statin-induced liver injury patterns are non-specific, making correlation over time challenging.

Purpose of the Study:

  • To evaluate changes in liver function tests (LFTs) over time in patients using statins.
  • To determine if a correlation exists between statin use and LFT derangement.
  • To assess the clinical significance of statin-associated LFT elevations.

Main Methods:

  • Retrospective observational cohort study.
  • Data collected from the National Institute of Cardiovascular Diseases (NICVD) database (July 1, 2018 - December 31, 2018).
  • Included patients already on statin therapy; LFTs recorded at baseline, 6, and 12 months, with exclusion of other liver disease causes.

Main Results:

  • 204 patients included; predominantly male (4:1 ratio).
  • Mean statin use duration: 19.92±14.34 months; common statins: rosuvastatin 20mg/day, atorvastatin 40 mg/day.
  • Both statins showed borderline LFT elevations (<2x ULN), more pronounced with atorvastatin 40 mg/day; elevations persisted without improvement.

Conclusions:

  • Statins are associated with dose-dependent, borderline elevations in LFTs over time.
  • These LFT derangements are clinically and statistically insignificant.
  • Physicians should not hesitate to prescribe or continue statins due to these minor LFT changes.